Info
Schedule 13D

BML Investment Partners, L.P. - Significant Ownership

Signature - Title: Braden M Leonard - Braden M Leonard - Managing Member of BML Capital Management, LLC
Location: Zionsville, IN
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by BML Investment Partners, L.P..

Significant Ownership of BML Investment Partners, L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ANTX	AN2 Therapeutics, Inc.	Common Stock, par value $0.00001 per share	19.1%	$7.42M		5.75M	0%	BML Investment Partners, L.P.	May 7, 2025
ADVM	Adverum Biotechnologies, Inc.	Common Stock, par value $0.0001 per share	15.6%		$1.6M	3.25M	+12.7%	Leonard Braden Michael	May 19, 2025
ACRS	Aclaris Therapeutics, Inc.	Common Stock, $0.00001 par value	13.3%	$21.8M		14.3M		BML Investment Partners, L.P.	Dec 31, 2024
ACHL	Achilles Therapeutics plc	American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share	9.97%	$6.07M		4.1M		BML Investment Partners, L.P.	Dec 31, 2024
ELEV	Elevation Oncology, Inc.	Common stock, par value $0.0001 per share	9.9%	$2.18M		5.89M	0%	BML Investment Partners, L.P.	Apr 16, 2025
EPIX	ESSA Pharma Inc.	Common Shares	9.5%	$7.6M	$69K	4.22M	+0.92%	BML Investment Partners, L.P.	Apr 24, 2025
AVIR	Atea Pharmaceuticals, Inc.	Common Stock, par value $0.001 per share	8.5%	$21.3M		7.22M		Leonard Braden Michael	Dec 13, 2024
THRD	Third Harmonic Bio, Inc.	Common Stock, par value $0.0001 per share	8.2%	$19.2M		3.72M		BML Investment Partners, L.P.	Feb 11, 2025
ATHA	Athira Pharma Inc.	Common Stock, $0.0001 par value	7.8%	$848K		3.03M		Leonard Braden Michael	Dec 31, 2024
IKNA	Ikena Oncology, Inc.	Common Stock, par value $0.001 per share	7.6%	$3.86M		3.65M	0%	Leonard Braden Michael	Dec 31, 2024
LVTX	LAVA Therapeutics N.V.	Common shares, par value $0.14 per share	7.4%	$2.7M		1.96M		BML Investment Partners, L.P.	Feb 26, 2025
PMVP	PMV Pharmaceuticals, Inc.	Common Stock, $0.00001 par value per share	6.7%	$3.74M		3.47M		BML Investment Partners, L.P.	Dec 31, 2024
TIL	Instil Bio, Inc.	Common Stock, $0.000001 par value per share	6.7%	$136K		440K		Leonard Braden Michael	Dec 31, 2024
ORMP	ORAMED PHARMACEUTICALS INC.	Common Stock par value $0.012 per share	6.55%	$5.82M		2.64M		BML Investment Partners, L.P.	Dec 31, 2024
KZR	Kezar Life Sciences, Inc.	Common Stock, $0.001 par value	5.1%	$284K		369K		BML Investment Partners, L.P.	Feb 28, 2025
WHWK	Aadi Bioscience, Inc.	Common stock, par value $0.0001 per share	4.98%	$3.75M	-$331K	2.44M	0%	Leonard Braden Michael	Mar 5, 2025
CLYM	Climb Bio, Inc.	Common Stock, par value $0.0001 per share	0%	$0		0		BML Investment Partners, L.P.	Dec 31, 2024
TECX	Tectonic Therapeutic, Inc.	Common Stock, $0.0001 par value per share	0%	$0		0		BML Investment Partners, L.P.	Dec 31, 2024

Showing 1 to 18 of 18 entries

Schedules 13D/G Reported by BML Investment Partners, L.P.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.